combined
Monsanto shareholders back Bayer deal, CEO hopeful of U.S. approval
December 13, 2016 by admin · Leave a Comment
Shareholders of U.S. seeds and agrochemicals company Monsanto Co approved the company's $66 billion acquisition by Bayer AG on Tuesday, a deal that still requires regulatory approval to close as expected in late 2017. Increased research and development spending by the combined companies and plans to develop a global seeds …
Read the original here:
Monsanto shareholders back Bayer deal, CEO hopeful of U.S. approval
combined
Apple will not give first-weekend sales of iPhone 7
September 8, 2016 by elegant · Leave a Comment
By Julia Love SAN FRANCISCO (Reuters) – Apple Inc will not release first-weekend sales of its new iPhone 7, the company said on Thursday, making it harder for analysts to get a …
Continued here:
Apple will not give first-weekend sales of iPhone 7
combined
Dell to cut 2,000-3,000 jobs as EMC deal closes: Bloomberg
September 8, 2016 by publisher · Leave a Comment
Most of the job cuts will be in the United States, Bloomberg reported on Thursday, citing people familiar with the matter. The layoffs will be mainly in supply chain, marketing and general and administrative divisions, Bloomberg said, adding that the combined company has 140,000 employees. “As is common with deals of this size, there will be some overlaps we will need to manage
Read more from the original source:
Dell to cut 2,000-3,000 jobs as EMC deal closes: Bloomberg
combined
Dow Chemical, DuPont in merger talks: sources
December 9, 2015 by creative · Leave a Comment
Dow Chemical Co and DuPont are in talks to merge, creating a chemicals giant with a market value of more than $120 billion that could then break up into different businesses, people familiar with the matter said on Tuesday. Following what would be structured as a merger of equals, the combined company could split into material sciences, specialty products and agrochemicals, the people said, cautioning that the…
Originally posted here:
Dow Chemical, DuPont in merger talks: sources
combined
Exclusive: Pfizer, Allergan CEOs agree on combined company roles – sources
November 21, 2015 by elegant · Leave a Comment
Pfizer Inc and Allergan Inc chief executives have agreed on the roles they would assume in a combined company, removing one of the last hurdles to the largest ever healthcare merger, people familiar with the matter said. Pfizer CEO Ian Read will be CEO of the combined company, while Allergan CEO Brent Saunders will have another very senior role, the people said on Friday, without providing more details. Pfizer and Allergan declined to comment.
Original post:
Exclusive: Pfizer, Allergan CEOs agree on combined company roles – sources